Navigation Links
Raf in Medical News

Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer

...volved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is also being evaluated by the companies, international study groups...

Sunesis Pharmaceuticals Receives Milestone Payment From Biogen Idec

...ogen Idec (Nasdaq: BIIB ) for the selection of a raf kinase inhibitor development candidate for the tre...ducting IND-enabling GLP preclinical work with the raf kinase development candidate. "While our inte...ed progress being made by Biogen Idec to advance a raf kinase inhibitor toward the clinic," said Daniel S...

Bladder Cancer No Longer a Death Sentence

...uency Ablation (RAF), a guided imagery surgery where a needle like probe transmits microwaves into tumors causing the destruction of tumor cells. The raf destroyed the tumors, but he was told they would come back - there is no mainstream cure for his cancer. Daniels then began researching alternati...

Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer

...olved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is also being evaluated by the companies, international study groups, g...

Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer

...olved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar, which is co-developed by Bayer Healthcare Pharmaceuticals and Onyx Pharm...

Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer

...volved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Preclinical models have also demonstrated that Raf/MEK/ERK has a role in HCC; therefor...

Oncogene inhibits tumor suppressor to promote cancer: Study links B-RAF and LKB1

...d malignant melanoma cells that often have a mutation called "V600E" in the raf protein B-RAF. The RAF-MEK-ERK pathway is well established as a key regulat...l growth, proliferation, differentiation and survival. Mutations in the raf kinase B-RAF have been found in many types of human cancer but, while oncog...

DSS Research Announces Senior Health Risk Assessment Tool

...eling and DSS has national norms available for users. DSS provides full risk stratification in comparison to norms for your population, comparisons to raf scores and other detailed analyses. Results can be delivered in hardcopy or interactive web reporting. Seniors with chronic conditions and various ris...

Sunesis Pharmaceuticals' SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology

...a Phase 1 dose-escalating clinical trial in patients with advanced solid tumors. In addition, Sunesis is developing novel small molecule inhibitors of raf kinase and receptor tyrosine kinases in collaboration with Biogen Idec. About Sunesis Pharmaceuticals Sunesis is a clinical-stage biopharmaceutica...

The African Medical and Research Foundation (AMREF) Honors Merck & Co., Inc. with Global Corporate Philanthropy Award

...tain, Dr. Rees met his mentor Sir Archibald McIndoe, the surgeon renowned for having developed reconstructive surgical techniques to treat hundreds of raf fighter pilots whose planes went down in flames. Dr. Rees' training with Archie McIndoe literally changed his life - and began his lifelong commitment...

More>>

Raf in Medical Technology

Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint

...olved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is currently approved in more than 70 countries for the treatment of pa...

Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer

...olved in both cell proliferation (growth) and angiogenesis (blood supply) -- two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is currently approved in more than 40 countries for liver cancer and in more...

The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer

...olved in both cell proliferation (growth) and angiogenesis (blood supply) -- two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Preclinical models have also demonstrated that Raf/MEK/ERK has a role in HCC; therefor...

New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting

...olved in both cell proliferation (growth) and angiogenesis (blood supply) -- two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is also being evaluated by the companies, international study groups, govern...

Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study

...olved in both cell proliferation (growth) and angiogenesis (blood supply) -- two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is currently approved in more than 40 countries for liver cancer and in more...

Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology

...a Phase 1 dose-escalating clinical trial in patients with advanced solid tumors. In addition, Sunesis is developing novel small molecule inhibitors of raf kinase and other oncology kinases in collaboration with Biogen Idec. About Sunesis Pharmaceuticals Sunesis is a clinical-stage biopharmaceutical c...

Nexavar First FDA-Approved Drug Therapy for Liver Cancer

...volved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Preclinical models have also demonstrated that Raf/MEK/ERK has a role in HCC; therefor...

Cytokine Announces Oral Efficacy of Anti-Cytokine Semapimod

...hance its acceptability to patients and physicians. Semapimod is a synthetic guanylhydrazone that inhibits the activity of various kinases, including raf kinase, a key enzyme in the MAPK/ERK signal transduction pathway. Semapimod's inhibition of Raf-kinase decreases phosphorylation of MEK, thereby also ...

Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial

...olved in both cell proliferation (growth) and angiogenesis (blood supply) -- two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Preclinical models have also demonstrated that Raf/MEK/ERK has a role in HCC; therefor...

Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research

... SNS-314 is expected to begin Phase 1 clinical trials in the first half of 2007. In addition, Sunesis is developing novel small molecule inhibitors of raf kinase and other oncology kinases in collaboration with Biogen Idec. About Sunesis Pharmaceuticals Sunesis is a clinical-stage biopharmaceutica...
Raf in Biological Technology

Sunesis Reports Financial Results for the Second Quarter 2009

...ogen Idec (Nasdaq: BIIB ) for the selection of a raf kinase inhibitor development candidate for the tre...pate in the co-development and co-promotion of the raf kinase inhibitor resulting from this collaboration...nt with them, and $1.5 million for the Biogen Idec raf kinase inhibitor milestone referred to above. Reve...

Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting

...olved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is currently approved in more than 70 countries for the treatment of pa...

AgFeed Industries Enters Into Hog Genetic Program Arrangement with Hypor, the Pig Breeding Division of Hendrix Genetics B.V.

...ding technology innovation, offers AgFeed a robust breeding animal that thrives under all conditions. This is a key requirement in China today." raf Beeren, Director of Hypor Asia, continued "Hypor is committed to providing superior genetics which results in greater profitability for hog producers....

FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions

...volved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is currently approved in more than 40 countries for the treatment of liver c...

Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting

...olved in both cell proliferation (growth) and angiogenesis (blood supply) -- two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Nexavar is currently approved in more than 40 countries for the treatment of patient...

Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results

...a Phase 1 dose-escalating clinical trial in patients with advanced solid tumors. In addition, Sunesis is developing novel small molecule inhibitors of raf kinase and other protein kinases in collaboration with Biogen Idec. About Sunesis Pharmaceuticals Sunesis is a clinical-stage biopharmaceutical co...

Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Women's Cancer

...a Phase 1 dose-escalating clinical trial in patients with advanced solid tumors. In addition, Sunesis is developing novel small molecule inhibitors of raf kinase and receptor tyrosine kinases in collaboration with Biogen Idec. About Sunesis Pharmaceuticals Sunesis is a clinical-stage biopharmaceutica...

Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx

...volved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET. Preclinical models have also demonstrated that Raf/MEK/ERK has a role in HCC; therefor...

Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

...a Phase 1 dose-escalating clinical trial in patients with advanced solid tumors. In addition, Sunesis is developing novel small molecule inhibitors of raf kinase and other oncology kinases in collaboration with Biogen Idec. About Sunesis Pharmaceuticals Sunesis is a clinical-stage biopharmaceutical com...

In Vivo Signal Transduction Pathway Reporting Systems

... of the pathway and screening for drugs that promote or inhibit the activity of JNK, MAPK, PKA or other upstream signaling molecules (such as Ras, raf and JNKK). Conclusions The PathDetect in vivo signal transduction pathway reporting systems can be used to determine and map the signal tran...

More>>

Raf in Biological Definition

Oncogene

... Regulatory GTPases , for example, the Ras protein . Cytoplasmic Serine / Threonine kinases and their regulatory subunits , for example, the raf kinase , and cyclin-dependent kinases (through overexpression ). Adaptor proteins in signal transduction . Transcription factors . ...
Raf in Biological Dictionary

Oligodeoxyribonucleotide

...sphorothioate, previously shown to inhibit HIV-1 viral expression in chronically infected H9 cells, was fluorescently labeled to ... ... modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic ... oligodeoxyribonucleotide is associated with sensitization of human lar...
Other Tags
(Date:7/30/2015)... ... July 30, 2015 , ... The Clinical Data Interchange ... pleased to announce that data standards for clinical research in the areas of ... CDISC website . These three Therapeutic Area (TA) standards were developed per the ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... L-Alanyl-L-Glutamine for people on the go. With no water needed, the refreshing berry-flavored ... a simple way to get the natural ingredients that may help with body ...
(Date:7/30/2015)... ... ... Google recently announced that it will be disclosing any incidents involving its ... 8, 2015 article published by Nasdaq , the powerful tech company maintains that ... cars, which such industry players as Tesla CEO Elon Musk believe may very well ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Center,” to announce its position as one of Medicare’s top-rated care centers. ... members support the CMS rating system, which monitors health inspections, staffing, and ...
(Date:7/30/2015)... ... 2015 , ... Zejax is a New Way of Training ... , World renown body weight trainer, Paul Ziachik, announces today that he ... a person’s training capability. , The American College of Sports Medicine states that ...
Breaking Medicine News(10 mins):Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2
(Date:7/27/2015)... JOSE, Calif. , July 27, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... ® touchscreen solution for its stylish smartwatch. ... for its proven reliability, low power and highly ... a wet finger. Huawei designers also required a ...
(Date:7/23/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) has ... of the Biometrics Industry 2015 " report ... biometrics market is likely to witness significant growth ... the uptake of multiple technologies available. The year ... growth of biometrics in existing applications as well ...
(Date:7/21/2015)... , July 21, 2015 Passwords ... as seen in the recent U.S. Office of ... solution to the infosec conundrum, but developers and ... stored. To address this dilemma, Biometrics-as-a-Service provider HYPR ... Biometric Tokenization SDK for third party integration. ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4
Other Contents